tradingkey.logo
tradingkey.logo
Search

Dri Healthcare Comments On FDA Approval And Our Increased Investment In Kalvista Pharmaceuticals' Ekterly®

ReutersJul 8, 2025 11:28 AM
facebooktwitterlinkedin
View all comments0

- Dri Healthcare Trust DHT_u.TO:

  • DRI HEALTHCARE COMMENTS ON FDA APPROVAL AND OUR INCREASED INVESTMENT IN KALVISTA PHARMACEUTICALS' EKTERLY® (SEBETRALSTAT)

Further company coverage: [DHT_u.TO]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI